This compound is a protected amino acid derivative featuring a fluorenylmethoxycarbonyl (Fmoc) group and a tert-butyl ether. It serves as a pharmaceutical intermediate, primarily used in solid-phase peptide synthesis as a building block.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 3020708-11-3
(2S,4R)-4-(tert-butoxy)-1-{[(9H-fluoren-9-yl)methoxy]carbonyl}pyrrolidine-2-carboxylic acid
Fmoc-protected amino acid building block
(2S,4R)-4-tert-butoxy-1-(9H-fluoren-9-ylmethoxycarbonyl)piperidine-2-carboxylic acid
pharmaceutical intermediate
(2S,4S)-4-tert-butoxy-1-(9H-fluoren-9-ylmethoxycarbonyl)piperidine-2-carboxylic acid
Pharmaceutical intermediate
N3-L-Val-OH (CHA)
pharmaceutical intermediate for peptide synthesis
Glycinamide hydrochloride
pharmaceutical intermediate for peptide synthesis
(2R)-1,4-bis[(tert-butoxy)carbonyl]piperazine-2-carboxylic acid
pharmaceutical intermediate for peptide synthesis
L-Aspartic acid, bis(1,1-dimethylethyl) ester, hydrochloride
pharmaceutical intermediate for peptide synthesis
(2S,3S)-3-tert-butoxy-1-(9H-fluoren-9-ylmethoxycarbonyl)piperidine-2-carboxylic acid
Pharmaceutical intermediate
(2S,5R)-1-(9H-fluoren-9-ylmethoxycarbonyl)-5-[(2-methylpropan-2-yl)oxy]piperidine-2-carboxylic acid
XSFVPSLXHLZRHD-ZHRRBRCNSA-N
CC(C)(C)O[C@@H]1CC[C@H](N(C1)C(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24)C(=O)O
—